Woodline Partners logo

Woodline Partners

North America, California, United States, San Francisco

Description

Woodline Partners is a private equity firm that focuses on the healthcare and technology sectors.

Investor Profile

Woodline Partners has made 60 investments, with 13 in the past 12 months and 7% as lead.

Stage Focus

  • Post Ipo Equity (47%)
  • Series B (23%)
  • Series C (12%)
  • Series A (7%)
  • Series D (5%)
  • Series F (3%)
  • Private Equity (2%)
  • Series Unknown (2%)

Country Focus

  • United States (87%)
  • United Kingdom (5%)
  • Germany (3%)
  • Canada (2%)
  • Japan (2%)
  • Sweden (2%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Pharmaceutical
  • Medical
  • Life Science
  • Biopharma
  • Oncology
  • Precision Medicine
  • Information Technology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Woodline Partners frequently co-invest with?

EcoR1 Capital
North America, California, United States, San Francisco
Co-Investments: 12
Surveyor Capital
North America, Illinois, United States, Chicago
Co-Investments: 12
Casdin Capital
North America, New York, United States, New York
Co-Investments: 10
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 14
Deep Track Capital
North America, Connecticut, United States, Greenwich
Co-Investments: 11
Perceptive Advisors
North America, New York, United States, New York
Co-Investments: 10
Logos Capital
North America, California, United States, San Francisco
Co-Investments: 17
Janus Henderson Investors
Europe, England, United Kingdom, London
Co-Investments: 15
Fidelity
North America, Massachusetts, United States, Boston
Co-Investments: 10
Boxer Capital
North America, Florida, United States, Windermere
Co-Investments: 9

Which angels does Woodline Partners often collaborate with?

DL
Europe, East Sussex, United Kingdom, Eastbourne
Shared Deals: 1
BT
North America, Massachusetts, United States, Marblehead
Shared Deals: 1
AK
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Woodline Partners?

LEXEO Therapeutics

New York, New York, United States

LEXEO Therapeutics utilizes gene therapy to treat genetically defined cardiovascular and central nervous system diseases.

BiotechnologyLife ScienceTherapeutics
Post Ipo EquityMay 27, 2025
Amount Raised: $80,000,000
Rezolute

Louisville, Colorado, United States

Rezolute is a clinical-stage biopharma specializing in the development of drug therapies for patients with metabolic and orphan diseases.

BiotechnologyDiabetesHealth CareTherapeutics
Post Ipo EquityApr 23, 2025
Amount Raised: $96,900,000
Caris Life Sciences

Irving, Texas, United States

Caris Life Sciences develops molecular profiling and AI-driven technologies to support precision medicine in oncology.

Artificial Intelligence (AI)BiopharmaBiotechnologyHealth CareLife Science
Private EquityApr 7, 2025
Amount Raised: $168,000,000
Archive

Los Altos, California, United States

Archive is a technology company that builds innovative, scalable, and profitable resale businesses for global brands.

FashionMarketplaceRetail
Series BFeb 4, 2025
Amount Raised: $30,000,000
Tectonic Therapeutic

Allston, Massachusetts, United States

Tectonic Therapeutic is a biotechnology company which focuses on scientific research in biochemistry and molecular pharmacology.

Biotechnology
Post Ipo EquityFeb 3, 2025
Amount Raised: $185,000,000
Kala Pharmaceuticals

Waltham, Massachusetts, United States

Kala Pharmaceuticals develops novel treatments for diseases that affect mucosal tissues.

BiotechnologyHealth CareMedicalPharmaceutical
Post Ipo EquityDec 30, 2024
Amount Raised: $10,750,000
Olema Oncology

San Francisco, California, United States

Olema Oncology is a preclinical biotechnology company that develops new drugs for the treatment and prevention of breast cancer.

BiopharmaBiotechnologyHealth CareMedicalOncologyPharmaceutical
Post Ipo EquityDec 2, 2024
Amount Raised: $250,000,000
Blue Earth Therapeutics

Oxford, Oxfordshire, United Kingdom

Blue Earth Therapeutics is a radiopharmaceutical company that specializes in the advancement of radiotherapeutics to treat cancer patients.

Health CareMedicalPharmaceuticalTherapeutics
Series AOct 30, 2024
Amount Raised: $76,500,000
Eledon Pharmaceuticals

Irvine, California, United States

Eledon Pharmaceuticals is a biotechnology company developing treatments for people undergoing organ or cellular transplantation.

BiotechnologyHealth CareMedicalPharmaceutical
Post Ipo EquityOct 29, 2024
Amount Raised: $85,000,000
Formo

Berlin, Berlin, Germany

Formo is a cell-ag company that develops animal-free dairy products using nature-identical milk proteins from precision fermentation.

BiotechnologyFood and BeverageLife Science
Series BSep 9, 2024
Amount Raised: $61,000,000